2,2'-Bibenzo[d][1,3,2]dioxaborole
3-(4-Chloro-3-(o-tolyloxy)naphthalen-1-yl)-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione-iso-2
(4-(5-(2-Aminoethyl)benzo[d][1,3,2]dioxaborol-2-yl)phenyl)methanol
BCAT-IN-1
2-((4-Chloro-2,6-difluorobenzyl)amino)-7-oxo-5-propyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile
(3R)-3-(4-Chloro-3-(o-tolyloxy)naphthalen-1-yl)-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione
2-(4-Bromobutyl)benzo[d][1,3,2]dioxaborole
BAY-771
Sodium 4-methyl-5-oxohexanoate
2-(2-(4-(Hydroxymethyl)phenyl)benzo[d][1,3,2]dioxaborol-5-yl)acetic acid
2-(1-Bromoethyl)benzo[d][1,3,2]dioxaborole
BcATc Inhibitor 2
